Standard and Interpretation
Recommendations for diagnosis and treatment of systemic lupus erythematosus
Shen Nan, Zhao Yi, Duan Lihua, Song Lijun, Zeng Xiaofeng, Liu Yi, Zhao Yan, on behalf of Chinese Rheumatology Association
Published 2023-07-01
Cite as Chin J Intern Med, 2023, 62(7): 775-784. DOI: 10.3760/cma.j.cn112138-20221027-00793
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with complicated pathogenesis and diverse clinical manifestations. The current recommendations of the Chinese Rheumatology Association are based on a comprehensive investigation of evidence based medicine, domestic and international guidelines for SLE, and experts′ proposals, and aim to provide a more scientific and authoritative reference for the diagnosis and management of SLE. The recommendations focus on four aspects; clinical manifestations, laboratory evaluation, diagnosis and disease assessment, and disease treatment and monitoring. The goal of the recommendations is to standardize the diagnosis and treatment of SLE in China so as to improve the prognosis of SLE patients.
Key words:
Lupus erythematosus, systemic; Diagnosis; Treatment; Prognosis
Contributor Information
Shen Nan
Department of Rheumatology, Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai 200001, China
Zhao Yi
Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China
Duan Lihua
Department of Rheumatology and Clinical Immunology, Jiangxi Provincial People′s Hospital, Nanchang 330006, China
Song Lijun
Department of Rheumatology, Qilu Hospital of Shandong University, Jinan 250100, China
Zeng Xiaofeng
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Liu Yi
Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China
Zhao Yan
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
on behalf of Chinese Rheumatology Association
